Guidance for DPIA Practices: A New Whitepaper for EU-Funded Projects
As health research becomes increasingly data-driven, ensuring robust data protection and ethical handling of sensitive information is more important than ever. When dealing with technologies like Federated Learning and cross-border data sharing, the risks to privacy grow, and so does the need for clear, actionable guidance. To address this, ONCOVALUE is proud to have contributed […]
Tracking Cancer Over Time: ONCOVALUE’s Unique Annotated Dataset
ONCOVALUE has developed a unique annotated dataset to train an AI-based imaging tool designed to support the assessment of metastatic breast cancer. With Siemens Healthineers leading its development, the tool ultimately aims to help evaluate which therapies are effective by providing objective, image-based information on disease progression. Using longitudinal medical imaging data (i.e. imaging data […]
ONCOVALUE Joins the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) Cluster
We are excited to announce that ONCOVALUE has officially joined the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) cluster, a European initiative focused on advancing cancer research through the application of artificial intelligence (AI). The CS-AIW cluster brings together European projects dedicated to improving cancer outcomes. Through collaboration and shared expertise, this cluster aims […]
ONCOVALUE Consortium Meeting – March 2025
The fourth ONCOVALUE consortium meeting took place on March 4-5, 2025, in Copenhagen, Denmark. It was a pleasure to see familiar faces as consortium partners gathered to discuss the progress of the project. A special thank you to Rigshospitalet for hosting and providing an excellent setting for productive discussions. Over two days, participants had the […]
ONCOVALUE opens call for expressions of interest to participate in project’s validation activities
ONCOVALUE is a consortium of cancer institutes and commercial businesses that are working together to implement value-based oncology care by enabling and guiding cancer hospitals to collect, harmonize and analyse high-quality Real-World Data (RWD) in real-time, supporting cost-effectiveness evaluation of novel cancer therapies. The project is funded by the European Union under the call ‘HORIZON-HLTH […]
Advancing AI in cancer research: Insights from ONCOVALUE, EUCanImage, and RadioVal
An Exchange of Lessons Learned session brought together representatives from three European-funded projects: ONCOVALUE, EUCanImage, and RadioVal, to share experiences and challenges in developing artificial intelligence (AI) for cancer research.Organized by CiaoTech, ttopstart, and the University of Barcelona, the session served as a platform to reflect on challenges such as data accessibility, quality, and standardization, […]
Showcasing progress: ONCOVALUE’s presentation at ISPOR
Last Monday, Kevin Tittel, our ONCOVALUE researcher, proudly presented his first poster at the ISPOR conference in Barcelona. His poster highlighted the preliminary results of our feasibility study, conducted in collaboration with clinical partners from all participating centers as part of the ONCOVALUE consortium. This study aims to explore the current quality of our hospital […]
European AI Security Network (EASiNet) CrossTalk Event
We are pleased to announce the European AI Security Network (EASiNet) CrossTalk Event is taking place on October 22, 2024, in Brussels. This exclusive, invitation-only event will bring together 10 leading EU-funded projects in AI and cybersecurity, alongside key European authorities, to present innovative solutions for the healthcare sector. Featured projects, including ONCOVALUE, TRUMPET, FLUTE, ENCRYPT, HARPOCRATES, PAROMA-MED, KATY, AI4EOSC, EOSC-TITAN, and […]
Event X Life Science
Our partner CiaoTech/PNO joined the Event X Life Science, the premier Italian matchmaking and innovation event in the field of Life Sciences. This dynamic event was held on 8th and 9th, October 2024 in Firenze. This event serves as a vibrant platform where industry leaders, researchers, investors, public institutions, and media representatives convene to explore cutting-edge […]
ONCOVALUE installs ethics advisory board Independent body will monitor and advise on ethics and legal aspects of the research
Utrecht, 08-07-2024 – ONCOVALUE, a consortium of cancer hospitals and commercial companies that are working together to implement value-based oncology care, has installed its ethics advisory board. The board consists of respected leaders in their respective fields of expertise from a variety of European countries. The ONCOVALUE research focuses on enabling and guiding cancer hospitals […]